Nicholas Goldner
Founder at ResistanceBio, Inc.
Profile
Nicholas Goldner is the founder of Viosera Therapeutics Inc., resistanceBio, Inc. He is currently a venture partner at Pioneer Fund.
He holds a doctorate degree from Washington University in St. Louis and an undergraduate degree from Wisconsin Lutheran College.
Nicholas Goldner active positions
Companies | Position | Start |
---|---|---|
Pioneer Fund/NY/
Pioneer Fund/NY/ Investment ManagersFinance Pioneer Fund/NY/ is a venture capital firm founded by Jason Gray. The firm is headquartered in San Francisco, California. | Private Equity Investor | - |
ResistanceBio, Inc.
ResistanceBio, Inc. BiotechnologyHealth Technology ResistanceBio, Inc. is a company that focuses on overcoming treatment-resistant cancer. The company is based in San Carlos, CA. The company's mission is to defeat this type of cancer by developing a novel class of multi-targeted oncology treatments called Resistance Suppressing Therapy (REST). ResistanceBio was founded by Nicholas Goldner and Christopher Bulow, with Nicholas Goldner serving as the CEO since incorporation. | Founder | - |
Former positions of Nicholas Goldner
Companies | Position | End |
---|---|---|
Viosera Therapeutics Inc.
Viosera Therapeutics Inc. Miscellaneous Commercial ServicesCommercial Services Viosera Therapeutics Inc. engages in the research and develop services that predict and block drug resistance in cancer and bacteria. The company was founded by Christopher Bulow and Nicholas Goldner and is headquartered in St. Louis, MO. | Chief Executive Officer | - |
Training of Nicholas Goldner
Wisconsin Lutheran College | Undergraduate Degree |
Washington University in St. Louis | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 3 |
---|---|
Viosera Therapeutics Inc.
Viosera Therapeutics Inc. Miscellaneous Commercial ServicesCommercial Services Viosera Therapeutics Inc. engages in the research and develop services that predict and block drug resistance in cancer and bacteria. The company was founded by Christopher Bulow and Nicholas Goldner and is headquartered in St. Louis, MO. | Commercial Services |
Pioneer Fund/NY/
Pioneer Fund/NY/ Investment ManagersFinance Pioneer Fund/NY/ is a venture capital firm founded by Jason Gray. The firm is headquartered in San Francisco, California. | Finance |
ResistanceBio, Inc.
ResistanceBio, Inc. BiotechnologyHealth Technology ResistanceBio, Inc. is a company that focuses on overcoming treatment-resistant cancer. The company is based in San Carlos, CA. The company's mission is to defeat this type of cancer by developing a novel class of multi-targeted oncology treatments called Resistance Suppressing Therapy (REST). ResistanceBio was founded by Nicholas Goldner and Christopher Bulow, with Nicholas Goldner serving as the CEO since incorporation. | Health Technology |
- Stock Market
- Insiders
- Nicholas Goldner